Back to Blog

Does Vitamin C Prevent Colds? What 80 RCTs Actually Show

February 27, 2026·5 min read

Vitamin C and the common cold is one of the most studied relationships in all of nutritional science. Linus Pauling's 1970 book "Vitamin C and the Common Cold" set off decades of research — and the results are far more nuanced than either enthusiasts or skeptics typically admit. The Cochrane Collaboration has synthesized over 80 randomized controlled trials on this exact question. Here is what they actually found.

What the Cochrane Review Shows

The 2013 Cochrane review (updated 2023) by Hemilä and Chalker analyzed 29 trials involving regular supplementation in over 11,000 participants. The headline finding that never makes it onto supplement labels: regular vitamin C supplementation does not reduce the incidence of colds in the general population.

That is not a subtle finding. In population after population, people taking daily vitamin C were just as likely to catch a cold as those taking placebo.

However, two secondary findings are genuinely interesting. First, regular supplementation does modestly reduce cold duration — by about 8% in adults and 14% in children. That translates to roughly half a day shorter illness for adults. Real, but modest. Second, in people under extreme physical stress — marathon runners, skiers, soldiers doing heavy cold-weather training — regular vitamin C halved cold incidence. This is a consistent finding across multiple trials in these specific populations.

The third finding concerns therapeutic dosing: taking high-dose vitamin C after cold symptoms begin does not appear to reduce duration or severity in most trials. This is the "I feel a cold coming on, let me take a bunch of vitamin C" strategy — and the evidence does not support it.

Why 200mg Is the Threshold

Most people assume that if some vitamin C is good, more must be better. The pharmacokinetics argue otherwise. Plasma vitamin C reaches near-saturation at roughly 200mg per day in most individuals. Above that dose, absorption in the gut drops sharply and kidneys excrete the excess efficiently.

A study by Levine et al. published in PNAS measured plasma, tissue, and urine vitamin C concentrations across a range of doses. At 200mg per day, plasma levels were near-maximal. Doses of 500mg and 1000mg raised plasma levels only marginally while dramatically increasing urinary excretion. The Linus Pauling Institute recommendation of 400mg per day represents a modest buffer above saturation — reasonable but not dramatically different from 200mg in outcome.

The upper tolerable intake is set at 2000mg per day. Above this, osmotic diarrhea becomes common. Kidney stone formation from oxalate (a vitamin C metabolite) increases in susceptible individuals at chronic high doses.

The Forms and Timing Question

Does the form of vitamin C matter? Standard ascorbic acid performs identically to "buffered" forms (calcium ascorbate, sodium ascorbate) in absorption studies. Liposomal vitamin C does achieve higher plasma levels at equivalent doses — meaningful for therapeutic contexts, less so for general supplementation where 200mg already saturates normal plasma levels.

Timing matters mainly for iron absorption enhancement. Vitamin C taken with iron-containing meals or iron supplements dramatically improves non-heme iron absorption — a genuinely useful application, particularly for vegetarians and individuals with iron deficiency.

What Vitamin C Actually Does

Understanding why the cold-prevention evidence is disappointing requires understanding vitamin C's actual biological roles. It is an essential cofactor for collagen synthesis, a potent antioxidant in plasma and intracellular compartments, and plays a specific role in neutrophil and lymphocyte function.

The immune connection is real — but it operates via maintaining baseline immune function in adequate individuals, not by supercharging immune activity with higher doses. Deficiency clearly impairs immune function (scurvy patients are susceptible to infections). Sufficiency supports normal immune function. Mega-dosing does not appear to enhance immune function beyond what sufficiency already provides.

One area of genuine promise: intravenous vitamin C at pharmacological doses (10-100g) achieves plasma concentrations orders of magnitude above oral supplementation, with emerging evidence for benefits in severe sepsis and as adjunctive cancer treatment. This is a completely different physiological context from oral supplementation.

FAQ

Q: Should I take vitamin C at all?

If your diet is lacking in fruits and vegetables, supplementing 100-200mg daily is a reasonable insurance policy. If you eat a reasonably varied diet, you are likely already adequate. For people who do heavy endurance exercise in cold environments, regular vitamin C supplementation has genuine evidence for reducing cold frequency.

Q: Does vitamin C help with anything besides colds?

Yes. Strong evidence supports vitamin C for preventing and treating scurvy, enhancing non-heme iron absorption, and supporting collagen synthesis (relevant for wound healing). Emerging evidence for high-dose IV vitamin C in critical illness contexts. The evidence for cancer prevention, cardiovascular disease, and cognitive aging is weaker and inconsistent.

Q: What form should I take?

Plain ascorbic acid is as effective as any "advanced" form for general supplementation at typical doses. Save money on basic ascorbic acid. Liposomal forms make sense primarily if you need high doses and want to minimize GI side effects.

Related Articles

Track your supplements in Optimize.

Want to optimize your health?

Create your free account and start tracking what matters.

Sign Up Free